These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1158 related items for PubMed ID: 23216261

  • 1. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.
    Xu LF, Sun HL, Chen YT, Ni JY, Chen D, Luo JH, Zhou JX, Hu RM, Tan QY.
    J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261
    [Abstract] [Full Text] [Related]

  • 2. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y, Lang QB, Chen Z, Li B, Yu CQ, Zhu DZ, Huang XQ, Zhai XF, Ling CQ.
    Chin Med J (Engl); 2009 Sep 05; 122(17):1990-5. PubMed ID: 19781383
    [Abstract] [Full Text] [Related]

  • 3. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF, Jia ZY, Yang ZQ, Fan WL, Shi HB.
    Cardiovasc Intervent Radiol; 2017 Nov 05; 40(11):1748-1755. PubMed ID: 28681222
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L, Li HL, Guo CY, Luo SX.
    Korean J Radiol; 2018 Nov 05; 19(2):237-246. PubMed ID: 29520181
    [Abstract] [Full Text] [Related]

  • 5. Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
    Zhang R, Shen L, Zhao L, Guan Z, Chen Q, Li W.
    Diagn Interv Radiol; 2018 Jul 05; 24(4):219-224. PubMed ID: 29792289
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF.
    World J Gastroenterol; 2014 Dec 14; 20(46):17483-90. PubMed ID: 25516662
    [Abstract] [Full Text] [Related]

  • 7. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y, Huang G, Wang Y, Liang L, Peng B, Fan W, Yang J, Huang Y, Yao W, Li J.
    Oncologist; 2016 Dec 14; 21(12):1442-1449. PubMed ID: 27486202
    [Abstract] [Full Text] [Related]

  • 8. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
    Li HL, Ji WB, Zhao R, Duan WD, Chen YW, Wang XQ, Yu Q, Luo Y, Dong JH.
    World J Gastroenterol; 2015 Mar 28; 21(12):3599-606. PubMed ID: 25834326
    [Abstract] [Full Text] [Related]

  • 9. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
    Si ZM, Wang GZ, Qian S, Qu XD, Yan ZP, Liu R, Wang JH.
    J Vasc Interv Radiol; 2016 Oct 28; 27(10):1577-83. PubMed ID: 27103146
    [Abstract] [Full Text] [Related]

  • 10. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK.
    Korean J Intern Med; 2016 Mar 28; 31(2):242-52. PubMed ID: 26874512
    [Abstract] [Full Text] [Related]

  • 11. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS, Lu HZ, Cheng T, Zhou Y, Huang Y, Gao YC, Tang MY, Jiang HY, Lian ZP, Hou EC, Liang P.
    BMC Cancer; 2016 Nov 03; 16(1):834. PubMed ID: 27809890
    [Abstract] [Full Text] [Related]

  • 12. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.
    J Gastroenterol Hepatol; 2016 Feb 03; 31(2):442-9. PubMed ID: 26259976
    [Abstract] [Full Text] [Related]

  • 13. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.
    Chen J, Lai L, Lin Q, Huang W, Cai M, Zhu K, Huang M.
    Oncotarget; 2017 Jan 03; 8(1):408-417. PubMed ID: 27880724
    [Abstract] [Full Text] [Related]

  • 14. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec 03; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 15. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
    Zhao M, Wang JP, Pan CC, Li W, Huang ZL, Zhang L, Fang WJ, Jiang Y, Li XS, Wu PH.
    Eur J Radiol; 2012 Oct 03; 81(10):2717-25. PubMed ID: 22245655
    [Abstract] [Full Text] [Related]

  • 16. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
    Hyun D, Cho SK, Shin SW, Park KB, Park HS, Choo SW, Do YS, Choo IW, Lee MW, Rhim H, Lim HK.
    Cardiovasc Intervent Radiol; 2016 Mar 03; 39(3):417-25. PubMed ID: 26246215
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C, Sun L, Xu J, Zhao Y.
    World J Surg Oncol; 2016 Apr 02; 14():100. PubMed ID: 27038790
    [Abstract] [Full Text] [Related]

  • 18. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan.
    Gastroenterology; 2006 Aug 02; 131(2):461-9. PubMed ID: 16890600
    [Abstract] [Full Text] [Related]

  • 19. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, Lubner MG, Dalvie PS, Louis Hinshaw J, Brace CL, Ozkan OS, Lee FT, Laeseke P.
    Abdom Radiol (NY); 2018 Sep 02; 43(9):2497-2504. PubMed ID: 29450606
    [Abstract] [Full Text] [Related]

  • 20. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.
    Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, Yi CH.
    JAMA; 2008 Apr 09; 299(14):1669-77. PubMed ID: 18398079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.